Erica Kleinbrink

Ms. Erica Kleinbrink

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2017 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
MMMichael M Mendelson
Michael M Mendelson
RMRiccardo E Marioni
Riccardo E Marioni
RJRoby Joehanes
Roby Joehanes
CLChunyu Liu
Chunyu Liu
ÅHÅsa K Hedman
Åsa K Hedman
IDIan Deary
Ian Deary
The link between DNA methylation, obesity, and adiposity-related diseases in the general population remains uncertain. We conducted an association study of body mass index (BMI) and differential methylation for over 400,000 CpGs assayed by microarray in whole-blood-derived DNA from 3,743 participants in the Framingham Heart Study and the Lothian Birth Cohorts, with independent replication in three external cohorts of 4,055 participants. We examined variations in whole blood gene expression and conducted Mendelian randomization analyses to investigate the functional and clinical relevance of the findings. We identified novel and previously reported BMI-related differential methylation at 83 CpGs that replicated across cohorts; BMI-related differential methylation was associated with concurrent changes in the expression of genes in lipid metabolism pathways. Genetic instrumental variable analysis of alterations in methylation at one of the 83 replicated CpGs, cg11024682 (intronic to sterol regulatory element binding transcription factor 1 [SREBF1]), demonstrated links to BMI, adiposity-related traits, and coronary artery disease. Independent genetic instruments for expression of SREBF1 supported the findings linking methylation to adiposity and cardiometabolic disease. Methylation at a substantial proportion (16 of 83) of the identified loci was found to be secondary to differences in BMI. However, the cross-sectional nature of the data limits definitive causal determination. We present robust associations of BMI with differential DNA methylation at numerous loci in blood cells. BMI-related DNA methylation and gene expression provide mechanistic insights into the relationship between DNA methylation, obesity, and adiposity-related diseases.

10 July 2020 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
AMAlisa K. Manning
Alisa K. Manning
AGAnton Scott Goustin
Anton Scott Goustin
EKErica Kleinbrink
Erica Kleinbrink
PTPattaraporn Thepsuwan
Pattaraporn Thepsuwan
JCJuan Cai
Juan Cai
LEONARD LIPOVICHLEONARD LIPOVICH
LEONARD LIPOVICH
Aims: Causal transcripts at genomic loci associated with type 2 diabetes (T2D) are mostly unknown. The chr8p23.1 variant rs4841132, associated with an insulin-resistant diabetes risk phenotype, lies in the second exon of a long non-coding RNA (lncRNA) gene, LOC157273, located 175 kilobases from PPP1R3B, which encodes a key protein regulating insulin-mediated hepatic glycogen storage in humans. We hypothesized that LOC157273 regulates expression of PPP1R3B in human hepatocytes. Methods: We tested our hypothesis using Stellaris fluorescent in situ hybridization to assess subcellular localization of LOC157273; small interfering RNA (siRNA) knockdown of LOC157273, followed by RT-PCR to quantify LOC157273 and PPP1R3B expression; RNA-seq to quantify the whole-transcriptome gene expression response to LOC157273 knockdown; and an insulin-stimulated assay to measure hepatocyte glycogen deposition before and after knockdown. Results: We found that siRNA knockdown decreased LOC157273 transcript levels by approximately 80%, increased PPP1R3B mRNA levels by 1.7-fold, and increased glycogen deposition by >50% in primary human hepatocytes. An A/G heterozygous carrier (vs. three G/G carriers) had reduced LOC157273 abundance due to reduced transcription of the A allele and increased PPP1R3B expression and glycogen deposition. Conclusion: We show that the lncRNA LOC157273 is a negative regulator of PPP1R3B expression and glycogen deposition in human hepatocytes and a causal transcript at an insulin-resistant T2D risk locus.

15 February 2013 in Leukemia
Verified
Journal Article
Closed access
JCJ X Cheng
J X Cheng
JAJ Anastasi
J Anastasi
KWK Watanabe
K Watanabe
EKErica Kleinbrink
Erica Kleinbrink
EGE Grimley
E Grimley
JVJ W Vardiman
J W Vardiman

1 December 2016 in Open Biology
Verified
Journal Article
Open access
CLChin-Yo Lin
Chin-Yo Lin
EKErica Kleinbrink
Erica Kleinbrink
FDFabien Dachet
Fabien Dachet
JCJuan Cai
Juan Cai
DJDonghong Ju
Donghong Ju
LEONARD LIPOVICHLEONARD LIPOVICH
LEONARD LIPOVICH
Long non-coding RNAs (lncRNAs) are transcripts of a recently discovered class of genes which do not code for proteins. LncRNA genes are approximately as numerous as protein-coding genes in the human genome. However, comparatively little remains known about lncRNA functions. We globally interrogated changes in the lncRNA transcriptome of oestrogen receptor positive human breast cancer cells following treatment with oestrogen, and identified 127 oestrogen-responsive lncRNAs. Consistent with the emerging evidence that most human lncRNA genes lack homologues outside of primates, our evolutionary analysis revealed primate-specific lncRNAs downstream of oestrogen signalling. We demonstrate, using multiple functional assays to probe gain- and loss-of-function phenotypes in two oestrogen receptor positive human breast cancer cell lines, that two primate-specific oestrogen-responsive lncRNAs identified in this study (the oestrogen-repressed lncRNA BC041455, which reduces cell viability, and the oestrogen-induced lncRNA CR593775, which increases cell viability) exert previously unrecognized functions in cell proliferation and growth factor signalling pathways. The results suggest that oestrogen-responsive lncRNAs are capable of altering the proliferation and viability of human breast cancer cells. No effects on cellular phenotypes were associated with control transfections. As heretofore unappreciated components of key signalling pathways in cancers, including the MAP kinase pathway, lncRNAs hence represent a novel mechanism of action for oestrogen effects on cellular proliferation and viability phenotypes. This finding warrants further investigation in basic and translational studies of breast and potentially other types of cancers, has broad relevance to lncRNAs in other nuclear hormone receptor pathways, and should facilitate exploiting and targeting these cell viability modulating lncRNAs in post-genomic therapeutics.

1 February 2012 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
CHChani J. Hodonsky
Chani J. Hodonsky
EKErica Kleinbrink
Erica Kleinbrink
KCKira N. Charney
Kira N. Charney
MPMegana Prasad
Megana Prasad
SBSeneca L. Bessling
Seneca L. Bessling
AAAnthony Antonellis
Anthony Antonellis

1 June 2018 in The Pharmacogenomics Journal
Verified
Journal Article
Closed access
PDF file
MIMarguerite Irvin
Marguerite Irvin
CSColleen M. Sitlani
Colleen M. Sitlani
RNRaymond Noordam
Raymond Noordam
CAChristie L. Avery
Christie L. Avery
JBJoshua C. Bis
Joshua C. Bis
LLLeslie A. Lange
Leslie A. Lange